Patents by Inventor Tomislav BILJAN

Tomislav BILJAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240124393
    Abstract: Disclosed is a process for the preparation of Omaveloxolone and salts thereof, as well as intermediates thereof.
    Type: Application
    Filed: September 21, 2023
    Publication date: April 18, 2024
    Inventors: Tomislav Biljan, Ivana Sagud, Dubravka Pavlicic, Maja Matanovic Skugor
  • Publication number: 20240124461
    Abstract: The present disclosure provides new procedures and intermediates for the preparation of Zanubrutinib.
    Type: Application
    Filed: December 10, 2021
    Publication date: April 18, 2024
    Inventors: Tihamér Paál, Zsuzsa Potarine Juhasz, Tomislav Biljan, Irena Nekola, Moris Mihovilovic
  • Patent number: 11667646
    Abstract: Disclosed are solid state forms of Rucaparib and of Rucaparib salts, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: December 15, 2020
    Date of Patent: June 6, 2023
    Assignee: ASSIA CHEMICAL INDUSTRIES LTD.
    Inventors: Dijana S. Samec, Jasna Dogan, Tomislav Biljan, Maja M. Skugor, Moris Mihovilovic, Tina Mundorfer, Nikolina Janton, Mihaela Tuksar, Sara M. Pipercic, Nea Baus Topic
  • Publication number: 20210094962
    Abstract: Disclosed are solid state forms of Rucaparib and of Rucaparib salts, and pharmaceutical compositions thereof.
    Type: Application
    Filed: December 15, 2020
    Publication date: April 1, 2021
    Inventors: Dijana S. Samec, Jasna Dogan, Tomislav Biljan, Maja M. Skugor, Moris Mihovilovic, Tina Mundorfer, Nikolina Janton, Mihaela Tuksar, Sara M. Pipercic, Nea Baus Topic
  • Patent number: 10875870
    Abstract: Disclosed are solid state forms of Rucaparib and of Rucaparib salts, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: January 23, 2018
    Date of Patent: December 29, 2020
    Inventors: Dijana Skalec Samec, Jasna Dogan, Tomislav Biljan, Maja Matanovic Skugor, Moris Mihovilovic, Tina Mundorfer, Nikolina Janton, Mihaela Tuksar, Sara Morasi Pipercic, Nea Baus
  • Patent number: 10807953
    Abstract: The present disclosure relates to novel, safe and efficient processes for the synthesis of Pimavanserin and salts thereof, as well as novel intermediates that can be used in these processes.
    Type: Grant
    Filed: May 28, 2019
    Date of Patent: October 20, 2020
    Assignee: Pliva Hrvatska D.O.O.
    Inventors: Tomislav Biljan, Jasna Dogan, Leonid Metsger, Sara Morasi Pipercic, Marina Ratkaj, Maja Matanovic Skugor, Yi Wang
  • Publication number: 20190389871
    Abstract: Disclosed are solid state forms of Rucaparib and of Rucaparib salts, and pharmaceutical compositions thereof.
    Type: Application
    Filed: January 23, 2018
    Publication date: December 26, 2019
    Inventors: Dijana Skalec Samec, Jasna Dogan, Tomislav Biljan, Maja Matanovic Skugor, Moris Mihovilovic, Tina Mundorfer, Nikolina Janton, Mihaela Tuksar, Sara Morasi Pipercic, Nea Baus
  • Publication number: 20190276401
    Abstract: The present disclosure relates to novel, safe and efficient processes for the synthesis of Pimavanserin and salts thereof, as well as novel intermediates that can be used in these processes.
    Type: Application
    Filed: May 28, 2019
    Publication date: September 12, 2019
    Inventors: Tomislav BILJAN, Jasna DOGAN, Leonid METSGER, Sara Morasi PIPERCIC, Marina RATKAJ, Maja Matanovic SKUGOR, Yi WANG
  • Patent number: 10343993
    Abstract: The present disclosure relates to novel, safe and efficient processes for the synthesis of Pimavanserin and salts thereof, as well as novel intermediates that can be used in these processes.
    Type: Grant
    Filed: March 2, 2016
    Date of Patent: July 9, 2019
    Assignee: Pliva Hrvatska d.o.o.
    Inventors: Tomislav Biljan, Jasna Dogan, Leonid Metsger, Sara Morasi Pipercic, Marina Ratkaj, Maja Matanovic Skugor, Yi Wang
  • Publication number: 20180037549
    Abstract: The present disclosure relates to novel, safe and efficient processes for the synthesis of Pimavanserin and salts thereof, as well as novel intermediates that can be used in these processes.
    Type: Application
    Filed: March 2, 2016
    Publication date: February 8, 2018
    Inventors: Tomislav BILJAN, Jasna DOGAN, Leonid METSGER, Sara Morasi PIPERCIC, Marina RATKAJ, Maja Matanovic SKUGOR, Yi WANG
  • Patent number: 9012641
    Abstract: Salts of prasugrel were prepared including, for example, crystalline forms of prasugrel hydro bromide. These salts are useful, for example, in medicaments that inhibit the aggregation of platelets.
    Type: Grant
    Filed: July 22, 2014
    Date of Patent: April 21, 2015
    Assignee: Teva Pharmaceuticals Industries Ltd.
    Inventors: Mihaela Tuksar, Tomislav Biljan, Miroslav Zegarac
  • Publication number: 20140336217
    Abstract: Salts of prasugrel were prepared including, for example, crystalline forms of prasugrel hydro bromide. These salts are useful, for example, in medicaments that inhibit the aggregation of platelets.
    Type: Application
    Filed: July 22, 2014
    Publication date: November 13, 2014
    Inventors: Mihaela TUKSAR, Tomislav BILJAN, Miroslav ZEGARAC
  • Patent number: 8802854
    Abstract: Salts of prasugrel were prepared including, for example, crystalline forms of prasugrel hydrobromide. These salts are useful, for example, in medicaments that inhibit the aggregation of platelets.
    Type: Grant
    Filed: April 7, 2011
    Date of Patent: August 12, 2014
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Mihaela Tuksar, Tomislav Biljan, Miroslav Zegarac
  • Patent number: 8501960
    Abstract: The invention provides Saxagliptin Schiff bases, polymorphs of Saxagliptin and (1S,3S,5S)-2-[(2S)-2-propan-2-ylideneamino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile, processes for preparing Saxagliptin hydrates, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: May 5, 2011
    Date of Patent: August 6, 2013
    Assignee: Assia Chemical Industries Ltd.
    Inventors: Marina Ratkaj, Tomislav Biljan, Marina Marinkovic
  • Publication number: 20130085154
    Abstract: Salts of prasugrel were prepared including, for example, crystalline forms of prasugrel hydrobromide. These salts are useful, for example, in medicaments that inhibit the aggregation of platelets.
    Type: Application
    Filed: April 7, 2011
    Publication date: April 4, 2013
    Inventors: Mihaela Tuksar, Tomislav Biljan, Miroslav Zegarac
  • Publication number: 20110275687
    Abstract: The invention provides Saxagliptin Schiff bases, polymorphs of Saxagliptin and (1S,3S,5S)-2-[(2S)-2-propan-2-ylideneamino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile, processes for preparing Saxagliptin hydrates, and pharmaceutical compositions thereof.
    Type: Application
    Filed: May 5, 2011
    Publication date: November 10, 2011
    Inventors: Marina RATKAJ, Tomislav BILJAN, Marina MARINKOVIC